A diabetes and obesity medication shows potential to reduce alcohol cravings and relapse in early animal studies.

Researchers find that tirzepatide (Mounjaro) reduces alcohol consumption by 50% and prevents relapse by blunting the brain's reward system.

That innocent-looking donut might be triggering more powerful brain responses than the vodka it’s sometimes paired with. While society readily acknowledges alcohol’s addictive potential, we still ...

A medication currently used to treat diabetes and obesity may offer a new way to help people struggling with alcohol addiction. A recent study published in eBioMedicine found that the drug tirzepatide ...

Researchers have discovered that drugs like Ozempic for diabetes and obesity also improve alcohol use disorders and other ...

Addiction has causes that are neurobiological, psychological and structural. Treating these drivers is as important as managing the initial withdrawal. Medically managed withdrawal does not restore ...

New research by UB’s Research Institute on Addictions has identified a key mechanism in how aerobic exercise can help impact the brain in ways that may support treatment — and even prevention ...

A Slidell mother says a free program helped save her from a life of substance abuse. Now, she's encouraging others with the ...

Remarkable scientific progress over the past five decades has helped us develop knowledge of how drugs of abuse induce pleasure, reinforce use, and lead to the compulsive self-administration we call ...

In general, leaning into your friendships is one of the best ways to relax without alcohol. Meaningful human connections “release dopamine and opioids in our brain,” Lembke says. “We are social ...